Start New EnglishEspañol中文РусскийالعربيةTiếng ViệtFrançaisDeutsch한국어Tagalog Library Performance
ALL MEDICAL CODES IN CATEGORY Temporary Q codes

2025 HCPCS code Q4301

Activate™ Matrix, per square centimeter, a skin substitute used in wound care.

2025 HCPCS code Q5118

Biosimilar bevacizumab-bvzr (Zirabev), 10 mg injection for intravenous infusion.

2025 HCPCS code Q4128

Processed human dermal allografts, including FlexHD®, AlloPatch® HD, or Matrix HD, per square centimeter, for surgical use in wound healing and tissue repair.

2025 HCPCS code O1G

Influenza immunization.

2025 HCPCS code Q5131

Injection, adalimumab-aacf (Idacio), biosimilar, 20 mg

2025 HCPCS code Q4190

Artacent AC, 1 sq cm: Amniotic tissue-derived allograft used to promote healing and reduce inflammation and scarring.

2025 HCPCS code Q0247

Injection, sotrovimab, 500 mg.

2025 HCPCS code Q5106

Injection, epoetin alfa-epbx, biosimilar, (Retacrit) (for non-ESRD use), 1000 units

2025 HCPCS code Q4299

AmnioCore Pro+, per square centimeter. This code represents the supply of AmnioCore Pro+, a three-layer wound covering made from amniotic and chorionic membranes, used in wound care.

2025 HCPCS code Q5113

Injection, trastuzumab-pkrb, biosimilar (Herzuma®), 10 mg.

2025 HCPCS code Q5129

Injection, bevacizumab-adcd (Vegzelma), biosimilar, 10 mg.

2025 HCPCS code Q0518

Pharmacy supplying fee for HIV pre-exposure prophylaxis (PrEP) FDA-approved prescription oral drug, per 90 days.

2025 HCPCS code Q0163

Diphenhydramine hydrochloride 50 mg oral, used to treat nausea and vomiting caused by chemotherapy.

2025 HCPCS code Q0164

Prochlorperazine maleate, 5 mg, oral, FDA approved prescription anti-emetic, for use as a complete therapeutic substitute for an IV anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen.